SAGE THERAPEUTICS, INC.

Profile

Company Names

SAGE THERAPEUTICS, INC.

Addresses

215 FIRST STREET, CAMBRIDGE, MA 02142

Phone Numbers

617-299-8380

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, OTHER HEALTH CARE

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$697,986,998.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2020-12-31 
$649,986,998.00 
$649,986,998.00 
$0.00 
Equity 
2
2014-03-11 
$38,000,000.00 
$38,000,000.00 
$0.00 
Equity 
1
2014-01-07 
$10,000,000.00 
$20,000,000.00 
$10,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ELIZABETH 
 
BARRETT 
DIRECTOR
SAGE THERAPEUTICS, INC.   |  UROGEN PHARMA LTD.
MICHAEL 
 
CLOONAN 
EXECUTIVE OFFICER
SAGE THERAPEUTICS, INC.
MICHAEL 
F. 
COLA 
DIRECTOR
NUPATHE INC.   |  MEDGENICS, INC.   |  AEVI GENOMIC MEDICINE, INC.   |  SAGE THERAPEUTICS, INC.
ANNE MARIE 
 
COOK 
EXECUTIVE OFFICER
SAGE THERAPEUTICS, INC.
JAMES 
F. 
FRATES 
DIRECTOR
SAGE THERAPEUTICS, INC.
GENO 
 
GERMANO 
DIRECTOR
ELUCIDA ONCOLOGY, INC.   |  SAGE THERAPEUTICS, INC.
GEORGE 
 
GOLUMBESKI 
DIRECTOR
ACCELERON PHARMA INC   |  KSQ THERAPEUTICS, INC.   |  SHATTUCK LABS, INC.   |  SAGE THERAPEUTICS, INC.   |  CHROMA MEDICINE, INC.   |  JUDO BIO INC.
BARRY 
 
GREENE 
EXECUTIVE OFFICER, DIRECTOR
KARYOPHARM THERAPEUTICS INC.   |  VICARIOUS SURGICAL INC.   |  SAGE THERAPEUTICS, INC.   |  TRU PRECIOUS METALS CORP.   |  DEEP SEA MINERALS CORP.
KIMI 
 
IGUCHI 
EXECUTIVE OFFICER
SAGE THERAPEUTICS, INC.
JEFFERY 
M. 
JONAS 
EXECUTIVE OFFICER, DIRECTOR
SAGE THERAPEUTICS, INC.
JEFFREY 
M. 
JONAS 
EXECUTIVE OFFICER, DIRECTOR
CARA THERAPEUTICS INC   |  SAGE THERAPEUTICS, INC.
STEPHEN 
J. 
KANES 
EXECUTIVE OFFICER
SAGE THERAPEUTICS, INC.
ROBERT 
T. 
NELSEN 
DIRECTOR
IKARIA HOLDINGS INC   |  FATE THERAPEUTICS INC   |  NEUROGESX INC   |  SAGE THERAPEUTICS, INC.   |  ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND IX, L.P.   |  GRAIL, INC.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  ARCH VENTURE FUND XI, L.P.   |  ARCH VENTURE FUND XII, L.P.
STEVEN 
 
PAUL 
DIRECTOR
CONSTELLATION PHARMACEUTICALS INC   |  TAL MEDICAL INC.   |  SAGE THERAPEUTICS, INC.   |  VOYAGER THERAPEUTICS, INC.   |  SEAPORT THERAPEUTICS, INC.
ALBERT 
J. 
ROBICHAUD 
EXECUTIVE OFFICER
SAGE THERAPEUTICS, INC.
KEVIN 
 
STARR 
DIRECTOR
AFFERENT PHARMACEUTICALS, INC.   |  ZAFGEN, INC.   |  AGIOS PHARMACEUTICALS INC   |  PANOPTICA, INC.   |  MYOKARDIA INC   |  THIRD ROCK VENTURES III, L.P.   |  SAGE THERAPEUTICS, INC.   |  GLOBAL BLOOD THERAPEUTICS, INC.   |  DECIBEL THERAPEUTICS, INC.
KEVIN 
P. 
STARR 
DIRECTOR
SAGE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-01-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-12-31 
2014-03-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-11 
2014-01-21
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#